Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

  • Post published:July 5, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Voting Results of AGSM

Wesana Health Announces Voting Results of AGSM

  • Post published:June 9, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

  • Post published:March 21, 2023
  • Post category:Press Release
Read more about the article Wesana Health Announces Receipt of Short-Term Loan

Wesana Health Announces Receipt of Short-Term Loan

  • Post published:December 21, 2022
  • Post category:Press Release
Read more about the article Wesana Announces Sale of Clinic Management Services Organization

Wesana Announces Sale of Clinic Management Services Organization

  • Post published:September 3, 2022
  • Post category:Press Release
Read more about the article Wesana Announces Second Quarter 2022 Financial Results

Wesana Announces Second Quarter 2022 Financial Results

  • Post published:August 30, 2022
  • Post category:Press Release
Read more about the article Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

  • Post published:June 8, 2022
  • Post category:Press Release
Read more about the article Wesana Health Provides Strategic and Operational Updates

Wesana Health Provides Strategic and Operational Updates

  • Post published:January 12, 2022
  • Post category:Press Release
Read more about the article Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

  • Post published:January 11, 2022
  • Post category:Press Release
Read more about the article MAPS and Wesana Health Resume Negotiations

MAPS and Wesana Health Resume Negotiations

  • Post published:December 14, 2021
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More